We are a healthcare company committed to saving lifes. Our organisation mainly focuses on understating the needs of so many patients suffering from rare and often catastrophic diseases where there is a clear unmet medical need. We constantly seek to bring to Latin American' patients highly innovative therapies that can have a radical impact on the course of their condition and their quality of life. We pride ourself about always keeping at heart the well-being of the patients that we believe we can help.
| Website | http://www.valentechforlife.com |
| Revenue | $5 million |
| Employees | 74 (57 on RocketReach) |
| Founded | 2013 |
| Phone | (571) 300-2834 |
| Industry | Wholesale Drugs and Sundries, Drug Stores & Pharmacies, Pharmaceuticals, Retail, Orphan Drugs, Biotechnology, Personalised Medicine |
| Keywords | Rare Diseases, Unmet Medical Needs, Pharmaceutical, Pharma, Orphan Drugs, Pharmaceutical Research, Biotechnology, Medical Research, Biopharma, Drug Discovery, Drug Development, Life Sciences, Therapeutic Solutions, Clinical Research, Clinical Trials, Precision Medicine, Health Technology, Healthcare, Regulatory Affairs, Patient Advocacy |
| Competitors | Johnson & Johnson, Roche, AstraZeneca, Bristol Myers Squibb, Gilead Sciences, Pfizer, Novartis, Biogen, Lilly India, Merck AH +40 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Valentech Pharma employee's phone or email?
The Valentech Pharma annual revenue was $5 million in 2026.
Gabriel Munoz is the CEO of Valentech Pharma.
57 people are employed at Valentech Pharma.
The NAICS codes for Valentech Pharma are [32, 325, 32541, 3254].
The SIC codes for Valentech Pharma are [28, 283].